Vascular Risk After Kidney Transplantation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00374595|
Recruitment Status : Unknown
Verified March 2018 by Jennifer Larsen, MD, University of Nebraska.
Recruitment status was: Active, not recruiting
First Posted : September 11, 2006
Last Update Posted : April 2, 2018
Hypothesis: Nontraditional risk factors, such as inflammation, vitamin D deficiency, elevated PTH, insulin resistance, homocysteine, or uric acid, contribute to cardiovascular disease progression after kidney transplant.
The purpose of this study is to evaluate which traditional and nontraditional cardiovascular disease risk factors best predict progression of cardiovascular disease (CVD) using carotid intima media thickness performed by ultrasound, in kidney transplant patients.
|Condition or disease|
|Cardiovascular Disease Chronic Kidney Disease Diabetes Vitamin D Deficiency Hyperparathyroidism|
|Study Type :||Observational|
|Actual Enrollment :||342 participants|
|Official Title:||Vascular Risk After Kidney Transplantation|
|Study Start Date :||April 2006|
|Estimated Primary Completion Date :||March 29, 2019|
|Estimated Study Completion Date :||April 2019|
- Carotid intima media thickness [ Time Frame: 3 years ]defined by ultrasound
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00374595
|United States, Nebraska|
|University of Nebraska Medical Center|
|Omaha, Nebraska, United States, 68198-1230|
|Principal Investigator:||Jennifer L Larsen, MD||University of Nebraska|